艾斯創生醫股份有限公司

骨科臨床需求

傳統骨科軟組織手術時間長、傷口大,又由於組織周圍血管少,循環不佳、傷口癒合慢,導致病患術後復原時間長、術後併發症機高,於醫院端需要投入更多成本進行感染照護並增加抗生素的使用、消耗更多醫療資源與人員照護時間增長。

Clinical Unmet Needs

High postoperative infection rate (15%) and injuries of surrounding nerves caused by surgery are the most common clinical issues due to the limited surgical methods for orthopedic soft tissue trauma. With these issues, more antibiotics and medical resources need to be utilized for infection care at the hospital domain while patients suffer from postoperative pain and long recovery time (6 months).

創新解決方案

以創新導引微創手術進行軟組織縫合,可顯著優化手術成效。於醫院端,可使醫生縮短1/2的手術時間、精準地完成組織縫合,顯著將術後併發症率由15%降低至1%,可降低抗生素使用與病患住床時間;於病患端,可將手術傷口縮小至0.8-1公分,並將術後復原時間由6個月縮短至3個月,使病能更快更好地回歸原本生活與運動。與其他醫療器材公司開發之同適應症修復產品在多項臨床測試中能顯著降低對於周圍組織的破壞。

A Novel Solution

Our team aims to minimize the damage to tissues caused by surgery and significantly reduce the postoperative infection rate by providing ultrasonic-guided medical device. Three clinical papers have been published using our technique which shows that the postoperative recovery time was shortened from 6 months to 4 months and the infection rate significantly decreased (15% to 2.8%). Using our technique, we can help the patient save $1,280 USD and greatly reduced the postoperative recovery pain. On the hospital aspect, the postoperative infection rates and operation time can be reduced which abridge the use of antibiotics and other medical resources.

骨科軟組織修復的全球市場估計將達到103億美元

The global market for orthopedic soft tissue repair is estimated to reach 10.3 billion in 2025

全球加速高齡化

2021年全球醫療器材市場規模為4,413億美元,年複合成長率可達6.5%,其中又以骨科醫療產品成長最為快速,推動市場增長的關鍵因素首先是因為高齡化社會中,老年人關節與骨骼肌肉系統退化,造成退化性骨科疾病患者數量的增加。

In 2021, the global medical equipment market is worth 441.3 billion U.S. dollars. The key factor driving market growth includes degenerative orthopedic diseases.

產業佈局

最主要的骨科醫療科技公司如Johnson & Johnson, Smith And Nephew,  Stryker Corporation相繼投入骨科微創醫療器材之開發,新型微創機器人、四肢骨科修復醫材、運動傷害修復為未來大廠佈局的重點項目。

Robot-assisted surgery system and regenerative therapy for spine, joints and soft tissue are the hot area in medtech.

新冠肺炎疫情之後

在全球老化與生活型態的轉變下骨科醫療產品之需求快速成長,預計到2026年將達到476億美元,而在後新冠肺炎時代,全球的戶外運動人口將急速上升,骨科運動醫學也備受全球關注。

In the Post-pandemic era, orthopedic sports medicine and devices will attracting global attention due to large exercise population.

關於我們

About US

艾斯創生醫專注於骨科精準與再生醫療。我們的使命是縮短骨科手術後復原時間與降低病患術後併發症。艾斯創生醫是一支始於臨床醫學研究的團隊,團隊結合三位臨床骨科醫師、醫學工程師等專長的人才,致力於骨科微創再生療技術與相關醫療器材開發,並於台大創創加速器、FITI、TAcc+加速器等計劃取得優異成果。團隊醫療技術獲得醫療院所類國家品質獎,同時發表於頂尖國際臨床期刊,是世界已發表論文中的最大案例數。

Astron Medtech is committed to developing new orthopedic soft tissue repair medical device. Our dynamic team includes orthopedic surgeons, medical engineers, and experienced marketing expertises. With this novel technology and hard work from our team, three clinical research were published in international clinical journals (Q1) and our company received SNQ award in 2021. Currently, we are collaborating with NTU hospital for more clinical evidence and estimate to launch our product by 2022.

Currently, We are seeking for clinical collaborators, distribution partners and investment in America. 

艾斯創生醫 / Astron Medtech

Contact:

ilin.tsai@astron-med.com

Address:

115 台北市南港區園區街3號17樓

No. 3, Yuanqu Street, Nangang District, Taipei City, 115

用 WordPress.com 建立自己的網站
立即開始使用